These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 23400545

  • 21. Apparent Diffusion Coefficient Value to Evaluate Tumor Response After Neoadjuvant Chemotherapy in Patients with Breast Cancer.
    Ramírez-Galván YA, Cardona-Huerta S, Elizondo-Riojas G, Álvarez-Villalobos NA.
    Acad Radiol; 2018 Feb; 25(2):179-187. PubMed ID: 29033147
    [Abstract] [Full Text] [Related]

  • 22. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [Abstract] [Full Text] [Related]

  • 23. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors.
    Razek AA, Gaballa G, Denewer A, Nada N.
    NMR Biomed; 2010 Jul; 23(6):619-23. PubMed ID: 20232453
    [Abstract] [Full Text] [Related]

  • 24. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L, Fangberget A, Geier O, Olsen DR, Seierstad T.
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [Abstract] [Full Text] [Related]

  • 25. The contrast-free diffusion MRI multiple index for the early prediction of pathological response to neoadjuvant chemotherapy in breast cancer.
    Zhang L, Ning N, Liang H, Zhao S, Gao X, Liu A, Song Q, Duan X, Yang J, Xie L.
    NMR Biomed; 2024 Nov; 37(11):e5176. PubMed ID: 38884131
    [Abstract] [Full Text] [Related]

  • 26. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Filip C, Haustermans K.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):863-70. PubMed ID: 21398048
    [Abstract] [Full Text] [Related]

  • 27. Changes in Apparent Diffusion Coefficient as Surrogate Marker for Changes in Ki-67 Index Due to Neoadjuvant Chemotherapy in Patients with Invasive Breast Cancer.
    Luo N, Ji Y, Huang X, Liu Y, Liu L, Jin G, Zhao X, Zhu X, Su D.
    Acad Radiol; 2019 Oct 01; 26(10):1352-1357. PubMed ID: 30711409
    [Abstract] [Full Text] [Related]

  • 28. Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer.
    Kim Y, Kim SH, Lee HW, Song BJ, Kang BJ, Lee A, Nam Y.
    Magn Reson Imaging; 2018 May 01; 48():27-33. PubMed ID: 29278762
    [Abstract] [Full Text] [Related]

  • 29. Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer.
    Charehbili A, Wasser MN, Smit VT, Putter H, van Leeuwen-Stok AE, Meershoek-Klein Kranenbarg WM, Liefers GJ, van de Velde CJ, Nortier JW, Kroep JR.
    Eur J Surg Oncol; 2014 Oct 01; 40(10):1216-21. PubMed ID: 25150151
    [Abstract] [Full Text] [Related]

  • 30. Diffusion-weighted MR imaging of locally advanced breast carcinoma: the optimal time window of predicting the early response to neoadjuvant chemotherapy.
    Yuan L, Li JJ, Li CQ, Yan CG, Cheng ZL, Wu YK, Hao P, Lin BQ, Xu YK.
    Cancer Imaging; 2018 Oct 29; 18(1):38. PubMed ID: 30373679
    [Abstract] [Full Text] [Related]

  • 31. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.
    Kim SH, Cha ES, Kim HS, Kang BJ, Choi JJ, Jung JH, Park YG, Suh YJ.
    J Magn Reson Imaging; 2009 Sep 29; 30(3):615-20. PubMed ID: 19711411
    [Abstract] [Full Text] [Related]

  • 32. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study.
    Wu X, Nerisho S, Dastidar P, Ryymin P, Järvenpää R, Pertovaara H, Eskola H, Kellokumpu-Lehtinen PL.
    NMR Biomed; 2013 Sep 29; 26(9):1186-94. PubMed ID: 23483722
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter study.
    Surov A, Pech M, Meyer HJ, Bitencourt AGV, Fujimoto H, Baxter GC, Santamaría G, Gilbert FJ, Wienke A.
    Cancer Imaging; 2022 Dec 09; 22(1):68. PubMed ID: 36494872
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient.
    Wu LA, Chang RF, Huang CS, Lu YS, Chen HH, Chen JY, Chang YC.
    J Magn Reson Imaging; 2015 Nov 09; 42(5):1407-20. PubMed ID: 25875904
    [Abstract] [Full Text] [Related]

  • 35. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
    Gaeta M, Benedetto C, Minutoli F, D'Angelo T, Amato E, Mazziotti S, Racchiusa S, Mormina E, Blandino A, Pergolizzi S.
    Acad Radiol; 2014 Oct 09; 21(10):1286-93. PubMed ID: 25088834
    [Abstract] [Full Text] [Related]

  • 36. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study.
    Genovesi D, Filippone A, Ausili Cèfaro G, Trignani M, Vinciguerra A, Augurio A, Di Tommaso M, Borzillo V, Sabatino F, Innocenti P, Liberatore E, Colecchia G, Tartaro A, Cotroneo AR.
    Eur J Surg Oncol; 2013 Oct 09; 39(10):1071-8. PubMed ID: 23953231
    [Abstract] [Full Text] [Related]

  • 37. Pre-operative assessment of residual disease in locally advanced breast cancer patients: A sequential study by quantitative diffusion weighted MRI as a function of therapy.
    Agarwal K, Sharma U, Sah RG, Mathur S, Hari S, Seenu V, Parshad R, Jagannathan NR.
    Magn Reson Imaging; 2017 Oct 09; 42():88-94. PubMed ID: 28627463
    [Abstract] [Full Text] [Related]

  • 38. Dynamic contrast-enhanced and diffusion-weighted MR imaging in early prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    Li J, Yan LL, Zhang HK, Wang Y, Xu SN, Li HL, Qu JR.
    Abdom Radiol (NY); 2022 Oct 09; 47(10):3394-3405. PubMed ID: 35916943
    [Abstract] [Full Text] [Related]

  • 39. Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer.
    Shaverdian N, Yang Y, Hu P, Hart S, Sheng K, Lamb J, Cao M, Agazaryan N, Thomas D, Steinberg M, Low DA, Lee P.
    Br J Radiol; 2017 Mar 09; 90(1071):20160739. PubMed ID: 28079398
    [Abstract] [Full Text] [Related]

  • 40. Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis.
    Nishimura R, Osako T, Okumura Y, Hayashi M, Arima N.
    Breast Cancer; 2010 Oct 09; 17(4):269-75. PubMed ID: 19730975
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.